Cypress Capital Management (Delaware)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-65,943
| Closed | -$3.62M | – | 16 |
|
|
2022
Q3 | $3.62M | Sell |
65,943
-1,050
| -2% | -$57.6K | 0.67% | 47 |
|
|
2022
Q2 | $4.43M | Sell |
66,993
-100
| -0.1% | -$6.61K | 0.66% | 55 |
|
|
2022
Q1 | $4.45M | Buy |
67,093
+450
| +0.7% | +$29.9K | 0.56% | 58 |
|
|
2021
Q4 | $3.88M | Buy |
66,643
+55,966
| +524% | +$3.26M | 0.44% | 62 |
|
|
2021
Q3 | $640K | Hold |
10,677
| – | – | 0.08% | 125 |
|
|
2021
Q2 | $640K | Buy |
10,677
+4,750
| +80% | +$285K | 0.08% | 126 |
|
|
2021
Q1 | $295K | Buy |
+5,927
| New | +$295K | 0.04% | 154 |
|